KR900005971A - 아미드작용기를 가지는 니트로옥시알킬 아민류함유의 제약조성물 및 이들 화합물의 제법 - Google Patents
아미드작용기를 가지는 니트로옥시알킬 아민류함유의 제약조성물 및 이들 화합물의 제법 Download PDFInfo
- Publication number
- KR900005971A KR900005971A KR1019890015231A KR890015231A KR900005971A KR 900005971 A KR900005971 A KR 900005971A KR 1019890015231 A KR1019890015231 A KR 1019890015231A KR 890015231 A KR890015231 A KR 890015231A KR 900005971 A KR900005971 A KR 900005971A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- hydrogen atom
- branched
- straight
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/14—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (18)
- 하기 일반식(Ⅰ)를 갖는 적어도 하나의 니트로옥시알킬아민 유도체를 함유하는 제약조성물과 이들의 광학활성 형태들 및 생리적으로 수용 가능한 이들이 염 :상기식에서 R1은 수소원자, 포화되었거나 혹은 불포화된 직쇄 또는 측쇄의 C1-C8알킬기, C3-C8-시클로알킬기 또는 C3-C8-시클로알켄일기, 아미노카르보닐기, C1-C6-알킬아미노카르보닐기 또는 디-C1-C6-알킬아미노카르보닐기이고, R2는 수소원자, 포화되었거나 불포화된 직쇄 또는 측쇄의 C1-C6-알킬기 또는 C3-C8-시클로알킬기 또는 C3-C8-시클로알켄일기이거나 혹은, R2는 R1및 그들이 (R1과 R2)결합되어 있는 질소 원자와 함께 C6이하를 함유하는 헤테로환지방족 고리(여기서 하나 또는 두개의 탄소원자들을 질소 원자나 혹은 산소원자로 대치할 수 있다)를 형성하고, A는 원자가 결합 또는 C8이하를 함유하는 직쇄 또는 측쇄의 알킬렌사슬(여기서 -CH2-기를 C3-C7-시클로알킬렌기로 대치할 수 있다)이고, B는 C1-C8을 함유하는 직쇄 또는 측쇄의 알킬렌사슬(여기서 -CH2-기를 C3-C7-시클로알킬렌기로 대치할 수 있다)이고, 및 X는 -NR3-CO-기 또는 -CO-NR3-기 인데, 여기서 R3는 수소원자이거나 또는 C6이하를 함유하는 포화되었거나 불포화된 알킬기이고 또는, X가 -NR3-CO-기인 경우에는 R3는 질소원자 및 그룹 A의 탄소원자와 함께 C4-C6를 함유하는 헤테로환고리에 다리를 놓거나 또는, R3는 R2, A 및 두개의 질소원자들과 함께 C3-C5를 함유하는 헤테로환 고리에 다리를 놓는다.
- 제1항에 있어서, R1은 수소원자, 직쇄 또는 측쇄의 C1-C8-알킬기, 아미노카르보닐기 또는 C1-C8알킬아미노카르보닐 기이고, R2는 수소원자이거나 직쇄 또는 측쇄의 C1-C6-알킬기 이거나 혹은, R1및 R2는 그들이 결합되어 있는 질소원자와 함께 아지리딘고리, 아제티딘고리, 피롤리딘고리, 피페리딘고리, 퍼히드로아제핀고리, 피페라진고리 또는 모르폴린고리를 형성함을 특징으로 하는 적어도 하나의 일반식(Ⅰ)을 갖는 니트로옥시 알킬아민 유도체를 함유하는 제약조성물.
- 제1항에 있어서, A는 원자가결합이거나 또는 메틸메틸렌기, 1-메틸에틸렌기, 디메틸메틸렌기, 1,1-디메틸에틸렌기, 1,1-디메틸트리메틸렌기, 1-메틸트리메틸렌기, 1,1-디메틸메틸렌기, 1-에틸메틸렌기, 1,1-디메틸트라메틸렌기, 1,2-디메틸트리메틸렌기, 2,2-디메틸트리메틸렌기, 3,3-디메틸트리메틸렌기, 1,1-디메틸펜타메틸렌기, 1,1-디메틸헥사메틸렌기 또는 1-메틸테트라메틸렌기 임을 특징으로 하는 적어도 하나의 일반식(Ⅰ)를 갖는 니트로옥시알킬아민 유도체를 함유하는 제약조성물.
- 제1항에 있어서, B는 에틸렌기, 1-메틸에틸렌기, 2-메틸에티렌기, 트리메틸렌기, 1-메틸트리메틸렌기, 3-메틸트리메틸렌기, 테트라메틸렌기, 판타메틸렌기, 1-메틸테트라메틸렌기, 1-에틸트리메틸렌기, 헥사메틸렌기, 1-메틸펜타에틸렌기, 1-에틸테트라메틸렌기, 1-n프로필트리메틸렌기, 1,1-디메틸에틸렌기, 디메틸메틸렌기, 1,1-디메틸트리메틸렌기, 2,2-디메틸트리메틸렌기, 2,2-디메틸테트라메틸렌기 또는 1,1-디메틸헥사메틸렌기이거나 또는, 사슬 B의 -CH2-기는 시클로펜틸렌기, 1,2-, 1,3- 또는 1,4-시클로헥실렌기, 메틸렌-1,2-시클로헥실렌기, 메틸렌-1,3-시클로헥실렌기 또는 메티렌-1,4-시클로헥실렌기(여기서 시클로알킬렌기의 배열은 시스이거나 혹은 트란스일 수 있다)에 의해 대치됨을 특징으로 하는 적어도 하나의 일반식(Ⅰ)를 갖는 니트로옥시알킬아민유도체를 함유하는 제약조성물.
- 제1항에 있어서, R3는 수소원자이거나 C1-C6-알킬기 또는 C2-C6-알켄일기이거나 혹은, R3는 질소원자 및 그룹 A의 탄소원자와 함께 피롤리딘고리 또는 피페리딘고리를 형성하거나 혹은, R3는 R2, A 및 두개의 질소원자들과 함께 피페라진고리를 형성함을 특징으로 하는 적어도 하나의 일반식(Ⅰ)를 갖는 니트로옥시알킬아민유도체를 함유하는 제약조성물.
- 실질적으로 상기에 기재된 바와 같이, 제1항에 따르는 제약조성물들.
- 하기 일반식(Ⅰ)의 니트로옥시알킬아민 유도체와 이들의 광학활성 형태들 및 생리적으로 수용가능한 이들의 염 :상기식에서 R1은 수소원자, 포화되었거나 혹은 불포화된 직쇄 또는 측쇄의 C1-C8알킬기, C3-C8-시클로알킬기 또는 C3-C8-시클로알켄일기, 아미노카르보닐기, C1-C6-알킬아미노카르보닐기 또는 디-C1-C6-알킬아미노카르보닐기이고, R2는 수소원자, 포화되었거나 불포화된 직쇄 또는 측쇄의 C1-C6-알킬기 또는 C3-C8-시클로알킬기 또는 C3-C8-시클로알켄일기이거나 혹은, R2는 R1및 그들이 (R1과 R2) 결합되어 있는 질소 원자와 함께 C6이하를 함유하는 헤테로환지방족 고리(여기서 하나 또는 두개의 탄소원자들을 질소원자나 혹은 산소원자로 대치할 수 있다)를 형성하고, A는 원자가 결합 또는 C8이하를 함유하는 직쇄 또는 측쇄의 알킬렌사슬(여기서 -CH2-기를 C3-C7-시클로알킬렌기로 대치할 수 있다)이고, B는 C1-C8을 함유하는 직쇄 또는 측쇄의 알킬렌사슬(여기서 -CH2-기를 C3-C7-시클로알킬렌기로 대치할 수 있다)이고, 및 X는 -NR3-CO기 또는 -CO-NR3-기인데, 여기서 R3는 수소원자이거나 또는 C6이하를 함유하는 포화되었거나 불포화된 알킬기이고 또는, X가 -NR3- -CO-기인 경우에 R3는 질소원자 및 그룹 A의 탄소원자와 함께 C4-C6를 함유하는 헤테로환고리에 다리를 놓거나 또는, R3는 R2, A 및 두개의 질소원자들과 함께 C3-C5를 함유하는 헤테로환고리에 다리를 놓는다(단, X가 -NH-CO기 또는 -CO-NR3-기인 경우에 R1및 R2는 동시에 수소원자를 나타내지 않는다).
- 상기에서 특별히 예시된 제7항에 따르는 니트로옥시알킬아민 유도체들.
- 하기 일반식(Ⅰ)의 니트로옥시알킬아민유도체를 제조함에 있어서, a) 하기 일반식(Ⅱ)의 화합물을 질산염에스테르형성 반응에 처하거나, 또는 b) X가 -NR3-CO-기인 경우에 하기 일반식(Ⅲ)의 화합물을 하기 일반식(Ⅳ)의 화합물과 반응시키고, c) X가 -CO-NR3-기인 경우에 하기 일반식(Ⅴ)의 화합물을 하기 일반식(Ⅳ)의 화합물과 반응시키거나, 또는 d) 하기 일반식(Ⅶ)의 화합물을 일반식 R1-NCO(여기서 R1은 상기에서 정의된 의미를 갖는다)의 이소시안산염과 반응시키거나 또는 일반식 R1-NH-CO-Hal(여기서 R1은 상기에서 정의된 의미를 가지며 Hal은 염소원자 또는 브롬원자이다)의 할로포름산 유도체와 반응시킨 다음, 필요하다면 그렇게 하여 얻어진 화합물을 광학활성형태 혹은 생리적으로 수용가능한 염으로 전환시킴을 특징으로 하는 하기 일반식(Ⅰ)을 갖는 니트로옥시알킬아민 유도체들의 제법 :상기식에서 R1은 수소원자, 포화되었거나 혹은 불포화된 직쇄 또는 측쇄의 C1-C8알킬기, C3-C8-시클로알킬기 또는 C3-C8-시클로알켄일기, 아미노카르보닐기, C1-C6-알킬아미노카르보닐기 또는 디-C1-C6-알킬아미노카르보닐기이고, R2는 수소원자, 포화되었거나 불포화된 직쇄 또는 측쇄의 C1-C6-알킬기 또는 C3-C8-시클로알킬기 또는 C3-C8-시클로알켄일기이거나 혹은, R2는 R1및 그들이 (R1과 R2) 결합되어 있는 질소 원자와 함께 C6이하를 함유하는 헤테로환지방족 고리(여기서 하나 또는 두개의 탄소원자들을 질소원자나 혹은 산소원자로 대치할 수 있다)를 형성하고, A는 원자가 결합 또는 C8이하를 함유하는 직쇄 또는 측쇄의 알킬렌사슬(여기서 -CH2-기를 C3-C7-시클로알킬렌기로 대치할 수 있다)이고, B는 C1-C8을 함유하는 직쇄 또는 측쇄의 알킬렌사슬(여기서 -CH2-기를 C3-C7-시클로알킬렌기로 대치할 수 있다)이고, 및 X는 -NR3-CO기 또는 -CO-NR3-기인데, 여기서 R3는 수소원자이거나 또는 C6이하를 함유하는 포화되었거나 불포화된 알킬기이고 또는, X가 -NR3- -CO-기인 경우에 R3는 질소원자 및 그룹 A의 탄소원자와 함께 C4-C6를 함유하는 헤테로환고리에 다리를 놓거나 또는, R3는 R2, A 및 두개의 질소원자들과 함께 C3-C5를 함유하는 헤테로환고리에 다리를 놓는다(단, X가 -NH-CO기 또는 -CO-NR3-기인 경우에 R1및 R2는 동시에 수소원자를 나타내지 않는다).상기식에서 R1,R2,A,B 및 X는 상기에서 정의된 의미를 갖는다 ;상기식에서, A,R1,R2및 R3는 상기에서 정의된 의미를 갖는다 ;Z-CO-B-ONO2(Ⅳ)상기식에서 B는 상기에서 정의된 의미를 가지며 Z는 이탈기이다 ;HNR3-B-ONO2(Ⅴ)상기식에서 B 및 R3는 상기에서 정의된 의미를 갖는다 ;상기식에서 A,R1,R2및 Z는 상기에서 정의된 의미를 갖는다 ;R2-NH-A-X-B-NON2(Ⅶ)상기식에서 A,B,R2및 X는 상기에서 정의된 의미를 갖는다.
- 실질적으로 상기에 기재되었고 예시된 바와 같이, 제7항에 따르는 화합물들의 제조를 위한 제9항에 따르는 방법.
- 제9 또는 10항에 따르는 제법에 의해 언제나 제조되는 제7항에 따르는 화합물.
- R1,R2,A 및 X는 제1항에서 정의된 의미를 가지며 B는 직쇄 또는 측쇄의 C1-C8-알킬기(여기서 메틸렌기는 C3-C7-시클로알킬렌기로 대치된다)임을 특징으로 하는하기 일반식(Ⅱ)의 화합물들 :
- 상기에 기재되었고 예시된 제12항에 따르는 화합물들.
- 제1 내지 8항중의 어느 한 항에 따르는 니트로옥시알킬아민 유도체들의 제조를 위한 제12 또는 13항에 따르는 화합물들의 용도.
- 제1항에 따르는 일반식(Ⅰ)을 갖는 니트로옥시알킬아민 유도체들의 제조를 위한 제12 또는 13항에 따르는 화합물들의 용도.
- 심장병과 순환 계통 질병치료를 위한 제1 내지 6항중의 어느 한 항에 따르는 제약조성물.
- 제약조성물의 제조를 위한 제7 또는 8항에 따르는 화합물들의 용도.
- 심장병과 순환 계통 질병치료용 제약조성물의 제조를 위한 제7 또는 8항에 따르는 화합물들의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3836021.7 | 1988-10-22 | ||
DE3836021A DE3836021A1 (de) | 1988-10-22 | 1988-10-22 | Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen |
Publications (1)
Publication Number | Publication Date |
---|---|
KR900005971A true KR900005971A (ko) | 1990-05-07 |
Family
ID=6365691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890015231A KR900005971A (ko) | 1988-10-22 | 1989-10-21 | 아미드작용기를 가지는 니트로옥시알킬 아민류함유의 제약조성물 및 이들 화합물의 제법 |
Country Status (19)
Country | Link |
---|---|
US (1) | US5037849A (ko) |
EP (1) | EP0367019B1 (ko) |
JP (1) | JPH02169558A (ko) |
KR (1) | KR900005971A (ko) |
AT (1) | ATE89264T1 (ko) |
AU (1) | AU624187B2 (ko) |
CA (1) | CA2001255A1 (ko) |
DD (1) | DD286350A5 (ko) |
DE (2) | DE3836021A1 (ko) |
DK (1) | DK517689A (ko) |
ES (1) | ES2058435T3 (ko) |
FI (1) | FI895012A0 (ko) |
HU (2) | HUT58280A (ko) |
IE (1) | IE62021B1 (ko) |
IL (1) | IL92014A0 (ko) |
MX (1) | MX18027A (ko) |
NZ (1) | NZ231060A (ko) |
PT (1) | PT92047B (ko) |
ZA (1) | ZA897949B (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5428061A (en) * | 1988-09-15 | 1995-06-27 | Schwarz Pharma Ag | Organic nitrates and method for their preparation |
DE4004841A1 (de) * | 1990-02-16 | 1991-08-22 | Boehringer Mannheim Gmbh | Salpetersaeureester von cyclohexanol-derivaten |
JP3361836B2 (ja) * | 1991-07-04 | 2003-01-07 | 三共株式会社 | アミノ酸誘導体 |
FR2709753B1 (fr) * | 1993-09-09 | 1995-12-01 | Hoechst Lab | Nitrates organiques, leur procédé de préparation et leur application comme médicaments. |
DE4438959A1 (de) * | 1994-10-31 | 1996-05-02 | Schaeffler Waelzlager Kg | Mechanischer Ventilstößel |
US5925658A (en) * | 1995-03-02 | 1999-07-20 | Sankyo Company, Limited | Optically active thiazolidinone derivative |
WO1997000239A1 (fr) * | 1995-06-14 | 1997-01-03 | Sankyo Company, Limited | Medicament contre l'angine contenant un derive nitroxy comme ingredient actif |
EP0988282A2 (de) * | 1997-06-11 | 2000-03-29 | Isis Pharma Gmbh | Neue pentaerythritderivate, deren herstellung und verwendung sowie intermediate zur synthese derselben |
US7358393B2 (en) * | 2001-09-06 | 2008-04-15 | Lonza Ltd. | Method for preparing β-alaninamides |
EP2125695B1 (en) * | 2007-02-05 | 2016-10-26 | Nicox Science Ireland | Nitric oxide donor compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2991290A (en) * | 1957-03-20 | 1961-07-04 | Us Vitamin Corp | Nu-alkylamino-alpha-hydroxy-alkanoic acid amides |
NL112366C (ko) * | 1960-06-02 | |||
US3189646A (en) * | 1962-04-26 | 1965-06-15 | Coastal Interchemical Company | Process for the preparation of n-methylol amide derivatives |
DE2718393C2 (de) * | 1977-04-26 | 1985-05-09 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur Herstellung von für Prepolymere geeigneten hydroxylgruppenhaltigen Monoenaminen |
CH602501A5 (ko) * | 1975-11-14 | 1978-07-31 | Ciba Geigy Ag | |
EP0090063B1 (en) * | 1982-03-29 | 1985-09-11 | The Dow Chemical Company | Process for making n-(2-aminoethyl)amides from oxazolines and amines |
DE3443998A1 (de) * | 1984-12-01 | 1986-06-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
DE3512627A1 (de) * | 1985-04-06 | 1986-10-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel |
DE3705622A1 (de) * | 1987-02-21 | 1988-09-01 | Boehringer Mannheim Gmbh | Neue amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
-
1988
- 1988-10-22 DE DE3836021A patent/DE3836021A1/de not_active Withdrawn
-
1989
- 1989-10-17 IL IL92014A patent/IL92014A0/xx not_active IP Right Cessation
- 1989-10-18 EP EP89119301A patent/EP0367019B1/de not_active Expired - Lifetime
- 1989-10-18 DE DE8989119301T patent/DE58904337D1/de not_active Expired - Fee Related
- 1989-10-18 NZ NZ231060A patent/NZ231060A/en unknown
- 1989-10-18 ES ES89119301T patent/ES2058435T3/es not_active Expired - Lifetime
- 1989-10-18 AT AT89119301T patent/ATE89264T1/de not_active IP Right Cessation
- 1989-10-18 DK DK517689A patent/DK517689A/da not_active Application Discontinuation
- 1989-10-19 AU AU43546/89A patent/AU624187B2/en not_active Ceased
- 1989-10-19 MX MX1802789A patent/MX18027A/es unknown
- 1989-10-20 PT PT92047A patent/PT92047B/pt not_active IP Right Cessation
- 1989-10-20 US US07/424,452 patent/US5037849A/en not_active Expired - Fee Related
- 1989-10-20 ZA ZA897949A patent/ZA897949B/xx unknown
- 1989-10-20 IE IE337089A patent/IE62021B1/en not_active IP Right Cessation
- 1989-10-20 DD DD89333773A patent/DD286350A5/de not_active IP Right Cessation
- 1989-10-20 FI FI895012A patent/FI895012A0/fi not_active Application Discontinuation
- 1989-10-20 HU HU895391A patent/HUT58280A/hu unknown
- 1989-10-21 KR KR1019890015231A patent/KR900005971A/ko not_active Application Discontinuation
- 1989-10-23 JP JP1273908A patent/JPH02169558A/ja active Pending
- 1989-10-23 CA CA002001255A patent/CA2001255A1/en not_active Abandoned
-
1994
- 1994-10-07 HU HU94P/P00035P patent/HU210352A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
DK517689D0 (da) | 1989-10-18 |
DD286350A5 (de) | 1991-01-24 |
DK517689A (da) | 1990-04-23 |
IL92014A0 (en) | 1990-07-12 |
HUT58280A (en) | 1992-02-28 |
EP0367019B1 (de) | 1993-05-12 |
MX18027A (es) | 1994-01-31 |
IE893370L (en) | 1990-04-22 |
HU210352A9 (en) | 1995-03-28 |
ATE89264T1 (de) | 1993-05-15 |
US5037849A (en) | 1991-08-06 |
DE3836021A1 (de) | 1990-05-03 |
PT92047A (pt) | 1990-04-30 |
AU4354689A (en) | 1990-05-17 |
EP0367019A1 (de) | 1990-05-09 |
FI895012A0 (fi) | 1989-10-20 |
IE62021B1 (en) | 1994-12-14 |
AU624187B2 (en) | 1992-06-04 |
JPH02169558A (ja) | 1990-06-29 |
ES2058435T3 (es) | 1994-11-01 |
NZ231060A (en) | 1992-02-25 |
PT92047B (pt) | 1995-06-30 |
HU895391D0 (en) | 1990-01-28 |
ZA897949B (en) | 1990-07-25 |
CA2001255A1 (en) | 1990-04-22 |
DE58904337D1 (de) | 1993-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3070912D1 (en) | Pharmaceutical heterocyclic compounds, processes for their preparation and compositions containing them | |
IL104305A0 (en) | Piperazine derivatives,their preparation and pharmaceutical compositions containing them | |
ZA929815B (en) | New phosphonosuccinic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing these compounds | |
ATE178588T1 (de) | Amidino-derivate und ihre verwendung als no- synthase inhibitoren | |
KR880011125A (ko) | 헤테로 싸이클릭 화합물, 그의 제조방법 및 용도 | |
KR900005971A (ko) | 아미드작용기를 가지는 니트로옥시알킬 아민류함유의 제약조성물 및 이들 화합물의 제법 | |
ES8500902A1 (es) | Un procedimiento para la preparacion de un derivado del indol. | |
GB1447599A (en) | Derivatives of alpha-methyldopa | |
EE02950B1 (et) | Metüleenbisfosfoonhappe esteramiidderivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon | |
US3621043A (en) | N-substituted octadecadienoic acid amides as cholesterol lowering agents | |
CA1237129A (en) | Aminoguanidine derivatives and a process for the preparation thereof | |
KR900003156A (ko) | 진통제 화합물, 그의 제조방법 및 그를 함유하는 약학 조성물 | |
ATE241607T1 (de) | Epoxybernsteinsäureamid-derivate | |
KR910000607A (ko) | 새로운 에스테르 | |
KR910006309A (ko) | 인지질 및 인지질 유도체를 유효 성분으로 하는 항비루스성 약제 | |
EP0564499A1 (en) | Novel amines, process for producing them and medicaments containing said compounds. | |
ES8608873A1 (es) | Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-piridiln-furilmetil propilaminas. | |
BG100704A (en) | New piperazine derivatives and methods for their preparation as well as of the compounds containing them | |
FR2633292B1 (fr) | Nouveaux derives de la 20,21-dinoreburnamenine substitues en 15 par un groupement amine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les reenfermant | |
GB1341170A (en) | Alkyl sulphonic acid esters of 1,3,2-oxazaphospha-cyclic compounds | |
AR003109A1 (es) | Compuesto con actividad antitumoral importante y toxicidad baja y sal farmaceuticamente aceptable compuesto y composicion farmaceutica que locontiene | |
IL49666A (en) | 3-imino-1,3,4,5-tetrahydro-2,4-benzothiazepines,their production and pharmaceutical compositions containing them | |
ATE44741T1 (de) | 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |